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The membrane protein NADPH (nicotinamide adenine dinucleotide phosphate) oxidase Nox4 constitu-
tively generates reactive oxygen species differing from other NADPH oxidases activity, particularly in
Nox2 which needs a stimulus to be active. Although the precise mechanism of production of reactive oxy-
gen species by Nox2 is well characterized, the electronic transfer throughout Nox4 remains unclear. Our
study aims to investigate the initial electronic transfer step (diaphorase activity) of the cytosolic tail of
Nox4. For this purpose, we developed two different approaches to produce soluble and active truncated
Nox4 proteins. We synthesized soluble recombinant proteins either by in vitro translation or by bacteria
induction. While proteins obtained by bacteria induction demonstrate an activity of 4.4 ± 1.7 nmol/min/
nmol when measured against iodonitro tetrazolium chloride and 20.5 ± 2.8 nmol/min/nmol with cyto-
chrome c, the soluble proteins produced by cell-free expression system exhibit a diaphorase activity with
a turn-over of 26 ± 2.6 nmol/min/nmol when measured against iodonitro tetrazolium chloride and
48 ± 20.2 nmol/min/nmol with cytochrome c. Furthermore, the activity of the soluble proteins is consti-
tutive and does not need any stimulus. We also show that the cytosolic tail of the isoform Nox4B lacking
the ﬁrst NADPH binding site is unable to demonstrate any diaphorase activity pointing out the impor-
tance of this domain.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Reactive oxygen species (ROS), comprising superoxide anion
and its derivatives, play an essential role both to ﬁght against bac-
teria invasion in the immune system and to act as signaling mole-
cules in critical cellular events such as oxygen sensing,
proliferation and apoptosis. NADPH (nicotinamide adenine dinu-
cleotide phosphate) oxidases or Nox are the major sources of
ROS production and include seven members consisting of ﬁve
Nox (Nox1–Nox5) and two dual oxidases (Duox1 and Duox2).
These members are expressed in different types of tissue, and their
function, differ from each other. Nox2, also known as gp91phox, is
extensively studied and mainly expressed in phagocytic cells. Its
dysfunction leads to a speciﬁc rare disease named chronic granulo-
matose disease (CGD). Nox2 forms a stable heterodimer called
cytochrome b558 with a membrane associated catalytic partner
p22phox. Upon activation, cytosolic factors including p40phox,
p47phox, p67phox, and Rac1/2 translocate to the plasma mem-ll rights reserved.
er Universitaire de Grenoble,
oble Cedex 9, France.
en).brane to interact with the cytochrome b558 [1]. The conformation
of Nox2 then switches to an active form [2]. Nox2 C-terminus con-
tains a binding site for a ﬂavin adenine dinucleotide (FAD) and for a
NADPH compounds whereas the N-terminus side consists of six
transmembrane helices that reside two hemes stabilized by four
histidines residues [3]. In an active state, electrons travel from
the NADPH to the FAD then through two heme molecules in order
to reduce the oxygen leading to the generation of superoxide anion
at last [4]. The electronic transfer from the NADPH to the FAD is
also called diaphorase activity and has been well described [5,6].
Nox4 is widely expressed, but its role is primordial in kidney
tissue [7,8] where it is primary source of ROS production. The dys-
function of Nox4 activity has been linked to the development of
disease such as diabetes [9], hypertension [10], atherosclerosis
[11], and osteoarthritis [12]. In contrast to Nox2, the presence of
regulatory subunits is not necessary for Nox4 activity [13]. Fur-
thermore, unlike the other member of Nox’s family, Nox4 activity
is constitutive [7,12,14,15]. Nevertheless, the electron transfer
mechanism of Nox4 is not well studied.
Since Nox4 activity is unique compared to other Nox in terms of
regulation, we decide to characterize the diaphorase activity lo-
cated in the C terminus domain of Nox4 which contains the NADPH
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proaches to produce soluble and active recombinant proteins: (1)
an Escherichia coli based expression system and (2) an in vitro tran-
scriptional–translational technique. Using these two methods, we
are able to characterize a diaphorase activity for the portion of
Nox4 and show that this activity is constitutive. We also establish
that the ﬁrst NADPH binding site which is absent in the isoform
Nox4B is necessary to initiate the ﬁrst electronic transfer step.2. Materials and methods
2.1. Nox4 truncated constructs generation
The different constructions of Nox4 were obtained by PCR. The
forward primers (50-GGAATTCTCCATGGTTCACCATCATTTCGGTCA-
TAAGTC-3’ for N-Aqc and N-Bqc; 50-GGATGAGCGGCCGCCCAGTCAC
CATCATTTCGGTC-3’ for Aqc-C and Bqc-C; 50-GGAATTCTCCATGGTC
TTGCATGTTTCAGGAGGGCTGC-3’ for N-1TM; 50-GGATGAGCGGCCG
CGCCTTGCATGTTTCAGGAGGGCTGC-3’ for 1TM-C; 50-GGAATTCTCC
ATGGCCTCTACATATGCAATAAGAG-3’ for N-2TM, and 50-GGATGA
GCGGCCGCGCCTCTACATATGCAATAAGAG-3’ for 2TM-C) were de-
signed to introduce a NcoI site (underlined) or a NotI site (bold-
face). The reverse primers (50-GCGTTACTCGAGTCAGCTGAAAGA
CTCTTTATTGTATTC-3’ for all the N terminal his-tag constructions
or 50-GCGTTACTCGAGTTGCTGAAAGACTCTTTATTGTATTC-3’ for all
the C terminal his-tag positions) possess a XhoI site and a stop
codon (underline) for the N-terminal his-tag constructions. The
truncated Nox4 were directly cloned in pIVEX 2.3MCS, in pIVEX
2.4NdeI and pET30b vectors.
2.2. Protein extraction
BL21(kDE3)CodonPlus-RIL bacteria (Stratagen) were induced by
1 mM Isopropyl thiogalactoside (IPTG) at 16 C overnight. Bacteria
pellets were lyzed by sonication in lysis buffer (50 mM Tris pH7.5,
100 mM NaCl, 2 mM MgCl2, 2 lg/ml leupeptin, 2 lg/ml pepstatin,
10 lM TLCK or 50 mM Tris pH 7.6, 500 mM NaCl, 10 mM dithio-
threitol (DTT), 1% CHAPS, 2 lg/ml leupeptin, 2 lg/ml pepstatin,
10 lM TLCK), and the lysates were centrifuged at 10,000g at 4 C
for 10 min. The supernatant corresponding to the total protein con-
tent was collected and subsequently centrifuged at 46,000g 4 C for
30 min to separate the soluble from the insoluble fraction.
2.3. Inclusion bodies puriﬁcation
IPTG induced transformed bacteria were sonicated in lysis buf-
fer A (50 mM Tris pH7.5, 100 mM NaCl, 2 mM MgCl2, 2 lg/ml leu-
peptin, 2 lg/ml pepstatin, 10 lM TLCK). The homogenate was
centrifuged at 10,000g, 4 C for 10 min and the subsequent super-
natant was centrifuged at 46,000g, 4 C for 10 min. The resulting
pellet was resuspended in buffer A containing 2 M NaCl and then
centrifuged again. The pellet was resuspended in buffer A supple-
mented with 2% triton X-100. A series of centrifugation and pellet
resuspension were performed ﬁrst with buffer A containing 1 M
urea and then with buffer A containing 8 M urea and 1 mM glycine.
The solution was then centrifuged for the last time, and the super-
natant contains the inclusion bodies. A diagram of the procedure is
described in Supplementary Fig. S3.
2.4. Cell-free expression of different Nox4 truncated forms
Expression tests for each protein were performed using the
RTS™ HY100 (Roche Applied Science) according to the manufac-
turer’s instructions. Different compounds were used to optimize
the expression and the solubility (ﬁnal concentrations: 5 mMNonidet P40 (NP40), 0.1 mM n-dodecyl-b-D-maltoside (DDM),
0.1 mM/4 mM oxidized/reduced glutathione (GSH/GSSG), and
1:50 dilution GroE chaperone (Roche Applied Science, Ref.
03263690001). The reactions were performed for 20–24 h at
20 C. At the end of the incubation, the ﬁnal reaction (total pro-
teins) was centrifuged at 21,400g, 4 C for 30 min to separate the
soluble from the insoluble protein fraction. The expression of the
proteins at a large scale was performed with RTS™ HY500 Proteo-
Master (Roche Applied Science) in the Proteomaster™ apparatus at
20 C for 24 h with a 990 rpm shaking speed. The total protein
fraction was then centrifuged (21,400g at 4 C for 30 min), and
the supernatant was considered as the soluble fraction.2.5. Puriﬁcation of his-tag recombinant proteins
The soluble fraction was equilibrated with four column volumes
(CV) of buffer A and then loaded onto a column containing an ade-
quate pre-equilibrated resin. The column was washed extensively
with 20CV of buffer A + 10 mM imidazole, and the proteins were
eluted by a gradient of imidazole starting from 100 mM to 1 M.
The composition of the buffer A and resin used are indicated be-
low: (1) for inclusion bodies (buffer A: 50 mM Tris pH7.5,
100 mM NaCl, 2 mM MgCl2, 2 lg/ml leupeptin, 2 lg/ml pepstatin,
10 lM TLCK, 8 M urea, 1 mM glycine and resin: Ni-Sepharose™ 6
Fast-Flow (GE-Healthcare)); (2) for soluble fraction obtained from
transformed BL21(kDE3)CodonPlus-RIL bacteria (buffer A: 50 mM
Tris pH 7.6, 500 mM NaCl, 10 mM DTT, 1% CHAPS, 2 lg/ml leupep-
tin, 2 lg/ml pepstatin, 10 lM TLCK and resin: Ni–NTA); and (3) for
soluble proteins obtained by RTS™ (buffer A: sodium phosphate
150 mM pH 7.4, 300 mM NaCl, 20 mM imidazole, 0,1 mM DDM
and resin: TALON Polyhistidine-Tag Puriﬁcation Resins).2.6. Refolding protocol
Different compounds indicated in Supplementary Table 1 were
used to optimize the refolding conditions. These compounds were
randomly combined using the SAmBa software (http://
www.igs.cnrs-mrs.fr/samba/) [16] to generate different refolding
buffers. The refolding of puriﬁed protein solubilized in 8 M urea
was realized by a dilution method (40 folds) and then centrifuged
at 21,400g, 4 C for 30 min to separate the soluble from the insol-
uble fraction. The soluble fractions were analyzed by Coomassie
blue stained SDS–PAGE, and the solubility was evaluated by densi-
tometry analysis of the gel using Scion program (NIH, USA) in
comparison to the amount of proteins diluted with the same pro-
cedure in 8 M urea buffer which corresponded to 100% of solubil-
ity. The score obtained for each compound was calculated as
follows: the percentages of solubility in which the compound
was present were summarized and divided by the number of time
this compound appeared. A high score indicated a good solubiliza-
tion/refolding capacity of the compound.2.7. Cell-free system diaphorase activity assay
The capacity of electron transfer in vitro was evaluated using an
adapted protocol previously described [17]. Brieﬂy, 10 pmol of
puriﬁed proteins was incubated for 5 min at 4 C in PBS buffer con-
taining 10 lM FAD (with or without 300 lg of cytosol isolated
from HEK293E cells) and 100 lM INT (iodonitro tetrazolium chlo-
ride) or 100 lM cytochrome c. The reaction was initiated by the
addition of 150 lM NADPH, and the reduction of these compounds
was followed during 30 min (at 500 nm for INT, e500nm =
11 mM1 cm1 or at 550 nm for cytochrome c, e550nm =
21.1 mM1 cm1).
Fig. 1. Schematic representation of Nox4 and truncated forms used in this study. The top of the diagram shows an alignment of predicted hydrophobic domains of Nox4 by
different softwares. Transmembrane domains are represented by white cylinders. FAD and NADPH binding-sites are represented by gray and black boxes, respectively. Rare
codon sequences are represented at the bottom of the Nox4 full-length scheme. The bottom of the diagram illustrates the truncated Nox4 proteins used in the study.
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As well described for Nox2, the diaphorase activity takes place
at the cytosolic part of gp91phox [5,6,18,19]. This portion of
gp91phox protein possesses speciﬁc domains dedicated to the
binding of NADPH and FAD which are necessary to initiate the elec-
tron transfer. An analysis of Nox4 sequence reveals that the C-ter-
minal part of Nox4 also contains two conserved domains (Fig. 1).
In order to characterize the molecular mechanism involved in
the establishment of the electron transfer through Nox4, we gener-
ated a series of truncated Nox4 proteins containing the NADPH and
the FAD domains: 2-TM (177–578), 1-TM (206–578), and Aqc
(309–578) derived from the variant Nox4A and Bqc (309–578)
from the isoform Nox4B (Fig. 1). One of the NADPH binding do-
mains is missing in the sequence of Nox4B and this isoform has
been described as inactive [12,20]. Bqc proteins were used to
investigate whether the NADPH binding domain was indeed neces-
sary for the diaphorase activity or not. We used two different ap-
proaches to express those proteins. The ﬁrst was an E. coli based
expression system, and the second was an in vitro transcrip-
tional–translational technique.3.1. Expression of Nox4 truncated proteins by bacterial induction
Constructs described in Fig. 1 with a poly-histidine tag at the N-
terminus side were transformed into BL21(kDE3) bacteria. After
IPTG induction, we ﬁrst observed by western blot the presence of
the short forms of N-Aqc and N-Bqc proteins in addition of the cor-
rect predicted protein size (Fig. 2A). Since rare codons could lead to
a premature arrest of the protein synthesis [21,22], we analyzed
Nox4 nucleic acid sequence and found that there are two rare co-
dons clusters, AGG-AGA-ACC-AGG-AGA and AGA-AGA-CUA, lo-
cated at nucleic acids 273 and 1363, respectively (Fig. 1). Wewere able to avoid the expression of the short forms by using the
BL21(kDE3)CodonPlus-RIL bacterial strain which over-expresses
tRNA corresponding to those codons (Fig. 2B). However, N-2TM
proteins could not be synthesized probably due to the toxicity of
the over-expression of membrane proteins by bacteria [23].
We next evaluated the solubility of the synthesized protein and
unfortunately found that N-Aqc proteins were totally insoluble
(Fig. 2C) as previously reported for Nox2 [18]. An analysis of the
hydrophobic properties of Nox4 protein revealed a high hydropho-
bic domain at the ﬁrst NADPH binding site (Fig. 1). To counter-bal-
ance the negative effect of the hydrophobicity on the solubility of
the protein, we designed an approach in two steps. We ﬁrst puri-
ﬁed inclusion bodies of N-Aqc as described in Supplementary
Fig. S3 and performed an extensive screening of refolding condi-
tions. The screening process was described in the method section,
and an example is presented in Supplementary Fig. S2. Several sets
of refolding experiments were necessary to ﬁnd out the best con-
ditions. Data from refolding experiments revealed that a basic
solution with pH greater than 9 was important to solubilize/refold
the denaturated protein as compared to that with pH 7.4. More
interestingly, the NVoy polymer (NV10) and CHAPS at pH 7.4 also
had a positive effect on the refolding (Fig. 2D). Based on these re-
sults, we hypothesized that lysing directly induced bacteria with
the previously determined optimal refolding buffer may favor to-
ward a direct solubilization of the proteins and avoid the initial
inclusion bodies puriﬁcation step. Indeed, we were able to obtain
soluble proteins when induced bacteria were lysed in a buffer con-
taining 1% CHAPS (Fig. 2E).3.2. In vitro expression of Nox4 truncated proteins by cell-free system
Unlike cytosolic proteins, expression of functional membrane
protein remains challenging. Difﬁculties are mainly related to
Fig. 2. Expression of truncated Nox4 proteins by IPTG-induced E. coli bacteria: (A) Analysis of the expression of truncated forms of Nox4 protein expressed by BL21(kDE3)
IPTG induction. Stars indicate different molecular sizes of the truncated proteins due to the presence of rare codons in Nox4 nucleic sequence. (B) Expression of truncated
Nox4 proteins produced by IPTG induction of BL21(kDE3)Codon + RIL bacteria. (C) Analysis of the soluble fraction containing truncated Nox4 proteins. Star indicates the Nox4
N-Aqc protein. (D) Coomassie blue stained SDS–PAGE gel showing soluble N-Aqc proteins using 4 indicated refolding conditions. Composition of buffers: Na-Phosphate 50
mM pH 7.4; Glycine-NaOH pH 9. NV10 and CHAPS were added to the buffer at the ﬁnal concentration of 0.5 mM and 1%, respectively. (E) Direct solubilization of N-Aqc
proteins in the lysis buffer containing CHAPS as detergent. WB, western blot uses a monoclonal anti-histidine antibody. T, total; I, insoluble; and S, soluble.
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low yield and nonfunctional proteins when produced in bacteria.
Cell-free expression system has emerged as a powerful alternative
to cell-base expression systems to produce and study membrane
proteins [24]. We take advantage of this technology to synthesize
truncated Nox4 proteins. Using standard synthesis conditions pro-
vided by the manufacturer without additives, we are able to ex-
press all the truncated proteins including the 2TM protein which
cannot be synthesized through the cell base system. Nevertheless,
the expression levels are uneven and proteins are barely soluble
(Fig. 3, condition A).
We then optimized conditions to obtain soluble proteins by
adding the chaperone GroE, the redox couple GSH/GSSG and deter-
gents like Nonidet P40 (NP40) and DDM [25]. Our results show that
all parameters play an important role to obtain soluble proteins.
For example, the position of the poly-histidine inﬂuences the
amount of proteins produced as well as its solubility (Fig. 3 1TM,
E, F, and G). Interestingly, the use of the detergent DDM favorsFig. 3. (A) Western blot analysis of Nox4 full-length protein expressed by cell-free tr
expressed in a bacterial cell-free translation system by western blot. The table summariz
and GroE; D, DDM, GroE, and GSH/GSSG; E, NP40; F, NP40 and GroE; and G, NP40, GroE, a
to the presence of rare codons. The position of the tag is noted on the name of the protein
histidine tag. A monoclonal anti-histidine antibody was used.toward a better solubility of all constructs contrasting with the
addition of NP40 which, in some cases, annihilated the production
of soluble proteins (Fig. 3 Bqc and 2TM, E and G). Furthermore, the
addition of GroE and GSH/GSSG to DDM increases the solubility of
all the truncated proteins (Fig. 3C and D versus B).
Nevertheless, a higher concentration of DDM leads to a loss of
the solubility without affecting the total amount of proteins pro-
duced (Supplementary Fig. S1A). Although FAD is a natural sub-
strate, it does not signiﬁcantly increase the solubility
(Supplementary Fig. S1B). Finally, based on our results, we ﬁnd a
common optimized condition for the synthesis of all constructs:
0.1 mM of DDM, GroE and 0.1 mM/4 mM of GSH/GSSG. As previ-
ously described, we observed additional shorter protein bands only
with the Nter tag for the proteins 2TM and 1TM, but not with the
Cter tag (Fig. 3B). This phenomenon is particularly noticeable for
the full length Nox4 Nter tagged protein (Fig. 3A). We, therefore,
choose to use the C-terminal tagged proteins to eliminate the
interferences mediated by the rare codons. Indeed, the puriﬁcationanslation system. (B) Evaluation of the solubility of the Nox4 truncated proteins
es the total and soluble expression of the proteins. A, no additives; B, DDM; C, DDM
nd GSH/GSSG. Stars indicate additional molecular sizes of the truncated proteins due
itself where C and N are respectively corresponding to the C- and N-terminal poly-
Fig. 4. Diaphorase activity of puriﬁed truncated Nox4 proteins. (A) Coomassie blue stained SDS–PAGE gel showing puriﬁed soluble Aqc-C and Bqc-C proteins expressed by a
transcription/translation coupled system (left panel) and puriﬁed soluble N-Aqc expressed in BL21(kDE3)Codon + RIL bacteria (right panel). Diaphorase activity measured by
INT and cytochrome c of puriﬁed soluble Aqc-C and Bqc-C synthetized by a transcription/translation coupled system (B) or of puriﬁed soluble N-Aqc expressed in
BL21(kDE3)Codon + RIL bacteria (C). (D) Diaphorase activity measurement of the puriﬁed soluble Aqc-C in the presence or absence of 300 lg of cytosolic proteins extracted
from HEK293 cells.
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length form since the tag is missing in the uncompleted translated
proteins.3.3. Diaphorase activity of Nox4 truncated proteins
Next, we over-expressed Aqc and Bqc proteins in large scale fol-
lowing the optimized conditions obtained previously. The amount
of Aqc proteins obtained is 9 lg/mL of the reaction mixture for the
cell-free expression system compared to 0.9 lg/mL of the bacterial
culture media for the cell-based system. Puriﬁed soluble proteins
(Fig. 4A) were tested for the diaphorase activity.
The diaphorase activity of these proteins was measured by two
electron acceptors: INT (p-iodonitrotetrazolium) and cytochrome c.
The values of the speciﬁc diaphorase activity for the protein Aqc
obtained by RTS are 26 ± 2.6 nmol/min/nmol for INT and
48 ± 20.2 nmol/min/nmol for cytochrome c (Fig. 4B). We then com-
pared these values to the turnover rate of the protein Aqc puriﬁed
from the IPTG induced bacteria that are 4.4 ± 1.7 nmol/min/nmol
for INT and 20.5 ± 2.8 nmol/min/nmol for cytochrome c (Fig. 4C).
We observe that the electron acceptor cytochrome c gives a
higher rate for both proteins. Furthermore, the protein Aqc pro-
duced by a cell-based system has a lower speciﬁc activity com-
pared to the protein synthesized by the cell-free technology. This
difference may be due to a distinct folding state of the active pro-
teins. Indeed, in the case of the cell-free based system, the direct
contact of the detergent DDM and the chaperone GroE during the
protein synthesis process may have provided a better folding envi-
ronment. As expected, Bqc is unable to reduce any two electronic
acceptors, consistent with our previous studies showing that the
isoform Nox4B is inactive [12].
Unlike Nox2, the diaphorase activity of Aqc is constitutive, and
the addition of cytosolic factors is not necessary to reduce the elec-
tron acceptors [19]. Using two different methods of protein synthe-
sis, we demonstrate that the cytosolic domain of Nox4 is
responsible for Nox4 constitutive activity. Other authors using a
similar portion of the C-terminal part of Nox4 have made the same
observations [26,27].Nevertheless, a disparity in the turnover activity value is no-
ticed. For instance, a turnover of 100 min1 was observed by Jack-
son et al. whereas Nisimoto and his colleagues found a diaphorase
activity of 160 min1 when they measured with the cytochrome c.
The difference observed in both studies may be due to different
tags usage and buffer composition. To ﬁnd out whether Nox4
diaphorase activity could be stimulated by unknown cytosolic
components or not, we measure the turnover rate of Aqc in the
presence of cytosol extracted from HEK293 cell. We choose
HEK293 cells because they express endogenously Nox4. As shown
in Fig. 4D, the addition of the cytosol extract does not enhance Aqc
activity. Herein, we describe in this study two different optimized
methods to produce soluble and active truncated Nox4 proteins.
The ﬁrst method is based on the refolding of insoluble proteins
whereas the second is based on a direct folding of the proteins dur-
ing the translation process. Although the refolded truncated pro-
teins are fully functional, their diaphorase activity has a lower
turnover number compared to the folded proteins synthesized by
a cell-free system.
Furthermore, the yield obtained by the cell-free expression sys-
tem is 10 times higher. Our results show that the non-cell-base
expression system is more suitable to produce functional Nox4
proteins. We have also demonstrated that the C-terminal domain
of Nox4 is capable of generating a constitutive diaphorase activity.
This spontaneous transfer of electrons from NADPH to FAD is inde-
pendent of cytosolic factors isolated from HEK293 cells. We also
prove that the isoform Nox4B is unable to initiate the ﬁrst elec-
tronic transfer step. In conclusion, this approach could extend to
constitute a powerful tool to characterize step-by-step the elec-
tronic transfer mechanism throughout Nox4 protein as well as
other NADPH oxidases.Acknowledgments
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